Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.01 - $1.38 $2,150 - $296,702
-215,002 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.96 - $1.35 $17,826 - $25,068
18,569 Added 9.45%
215,002 $269,000
Q4 2021

Feb 14, 2022

SELL
$0.95 - $1.99 $171,866 - $360,014
-180,912 Reduced 47.94%
196,433 $228,000
Q3 2021

Nov 15, 2021

BUY
$1.74 - $2.33 $158,868 - $212,738
91,304 Added 31.92%
377,345 $725,000
Q2 2021

Aug 16, 2021

BUY
$2.06 - $2.82 $49,821 - $68,201
24,185 Added 9.24%
286,041 $669,000
Q1 2021

May 17, 2021

BUY
$2.35 - $4.01 $234,753 - $400,578
99,895 Added 61.68%
261,856 $710,000
Q4 2020

Feb 16, 2021

BUY
$1.91 - $2.67 $119,321 - $166,800
62,472 Added 62.79%
161,961 $392,000
Q3 2020

Nov 16, 2020

BUY
$1.81 - $5.53 $32,768 - $100,115
18,104 Added 22.24%
99,489 $228,000
Q2 2020

Aug 14, 2020

BUY
$1.66 - $3.06 $113,982 - $210,111
68,664 Added 539.77%
81,385 $187,000
Q1 2020

May 14, 2020

SELL
$1.26 - $2.73 $39,264 - $85,072
-31,162 Reduced 71.01%
12,721 $22,000
Q4 2019

Feb 14, 2020

SELL
$2.05 - $2.82 $149,574 - $205,755
-72,963 Reduced 62.44%
43,883 $91,000
Q3 2019

Nov 14, 2019

SELL
$2.9 - $4.07 $224,448 - $315,001
-77,396 Reduced 39.85%
116,846 $338,000
Q2 2019

Aug 14, 2019

BUY
$3.47 - $6.71 $674,019 - $1.3 Million
194,242 New
194,242 $761,000

Others Institutions Holding GNCA

# of Institutions
1
Shares Held
10K
Call Options Held
0
Put Options Held
0

About GENOCEA BIOSCIENCES, INC.


  • Ticker GNCA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,783,500
  • Description
  • Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...
More about GNCA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.